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ABSTRACT 
 
Purpose. To evaluate the relationship between menstrual cycle irregularity and several key 
variables, and to determine whether the odds of diabetic women self-reporting menstrual cycle 
irregularities is greater than non-diabetic women self-reporting menstrual cycle irregularities. 
Methods. A cross-sectional study was conducted using data from the Kentucky Women’s 
Health Registry from 2006 to 2014. The data was restricted based on age (used as a proxy for 
menopause status) and self-reported pregnancy and breastfeeding status, as well as eligibility to 
menstruate, yielding a final population of 4,256 participants for analysis. Basic statistical 
frequency analyses were conducted, stratified by menstrual cycle status. Bivariate analyses were 
conducted on the data to estimate odds ratios for menstrual irregularities based on diabetes status 
and adjusting for confounders. A logistic regression analysis was performed to estimate the 
adjusted odds women with diabetes reporting menstrual cycle irregularities. 
Results. The unadjusted odds of self-reported menstrual cycle irregularities were 
significantly greater in diabetic than non-diabetic women (OR = 2.09, p-value <0.05). This result 
was no longer significant after adjusting for confounders (OR = 1.17, p-value = 0.39). When 
subtypes of diabetes were considered for unadjusted analyses, type II diabetics taking insulin 
only (OR = 2.74, p-value < 0.05), type II diabetics controlling by diet alone (OR = 2.52, p-value 
< 0.05), and type II diabetics taking oral pills only (OR = 2.16, p-value < 0.05) yielded the 
largest odds of self-reporting menstrual cycle irregularities versus non-diabetic women. In the 
fully-adjusted model utilizing the diabetes subtypes variable, type II diabetes controlled by diet 
only was significant (OR = 3.36, p-value = 0.02). The reduced adjusted model showed a strong, 
statistically significant increase for the dichotomous diabetes variable compared to the result 
from the fully-adjusted model (OR = 1.53, p-value = 0.006). 
Conclusion. Results indicate a consistent relationship in self-reported menstrual cycle 
irregularities among diabetic women when compared with non-diabetic women. In the expanded 
diabetes variable model, type II diabetes controlled by diet only was significantly associated with 
menstrual cycle irregularities, though small numbers necessitate cautious interpretation. 
Multicollinearity, skewing, and bias could be impacting the results. Further analysis is needed to 
determine the relationship of diabetes and menstrual cycle irregularities in adult women. 
 
Keywords: menstruation, diabetes, menstrual irregularities, menstrual disturbances, menses 
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INTRODUCTION 
 
 Menstrual cycle irregularities, such as oligomenorrhea or amenorrhea, are an often-
overlooked aspect of women’s health that carries a high patient burden. Menstrual cycles are 
used as a general overall indicator of women’s health, and irregularities in the menstrual cycle 
could be indicative of several adverse conditions, such as fertility disorders.1-3 An irregular 
menstrual cycle is considered to be menstrual bleeding occurring more frequently than a 21 day 
cycle, less frequently than 35-day cycles, or an irregular bleeding pattern (such as bleeding 
between periods or abnormally heavy cycles).4 Currently, the most commonly prescribed 
treatments for the correction of menstrual cycle dysfunctions are various forms of hormone-
based contraceptives. Considering the pharmacoeconomical aspect of the patient burden 
associated with adhering to a birth control regimen. For example, a 2012 study found that 
women living in states mandating contraceptive coverage by private insurance companies had a 
greater odds of adhering to a consistent schedule.5 For these therapies to be effective, they must 
be taken consistently. However, costs associated with these therapeutics could play a significant 
role in adherence. Another 2012 study examined a population of women between ages 13 and 50 
who had purchased at least one oral contraceptive pill between 1996 and 2008.5 The data was 
compiled from the Medical Expenditures Panel Survey.6 Users of combined-hormone oral 
contraceptive pills spent an average of $16 per pack while users of progestin-only pills spent an 
average of $13 per pack, yielding an average yearly expenditure of $192 and $156 respectively.6 
While the study did not explicitly state an average out-of-pocket expenditure based on insurance 
status, the authors noted that women with private insurance were less likely than uninsured 
women to pay $15 or more per pack; Medicaid enrollees saw this likelihood decrease even 
further.5 A 2015 study found that this burden was significantly eased by the Affordable Care Act, 
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increasing substantially the proportion of women with no co-pay for contraceptives7, as well as 
increasing the proportion of women with insurance.  
 Comorbid health conditions, such as diabetes, may explain menstrual dysregulation in 
some women. Diabetes is one of the most common chronic diseases in the United States, and, 
indeed, within Kentucky. The CDC reports that 9.3% of the American population has diabetes8, 
and an age-adjusted estimate of 11.3% of women in Kentucky had diabetes as of 2014.9 This 
number is only expected to rise alongside the increasing obesity rate.  
 The relationship between diabetes and menstrual dysregulation in adult women is not 
well understood, given the inconsistent results from prior analyses and limited literature 
available on the subject. Using data from the Kentucky Women’s Health Registry (KWHR), this 
study will characterize menstrual cycle dysregulation among adult women in Kentucky and 
evaluate its risk factors, emphasizing its relationship to diabetes.  
 
Literature Review 
 Data on menstrual cycles are generally self-reported. Regarding the validity of the self-
reported data, a 2008 study found that “on average, women overestimated their cycle length by 
0.7 days”.2 Moreover, data from sexually active populations within the study were more accurate 
than data from unmarried women who are not sexually active.2 The authors note this difference 
could be due to the need for “family planning” methods among sexually active populations.2 
Menstrual cycle irregularities have been shown to be linked to many diseases, such as metabolic 
disorders.1 A 2016 Iranian study found significant risk for type 2 diabetes and pre-diabetes 
among women with irregular menstrual cycles when compared to women with regular menstrual 
cycles: the adjusted hazard ratios were 1.73 and 1.33, respectively.1 This finding may suggest 
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that diabetes and menstrual dysregulation share a common set of risk factors, or that disruptions 
in reproductive hormones may affect the endocrine system, or perhaps both.  
 Literature on the relationship between menstrual cycles and diabetes is limited, with most 
available studies focusing primarily on adolescent health and type 1 diabetes. The exact 
physiological relationship between the two is also not well-defined, though it seems that it hinges 
on gonadotropin-releasing hormone (GnRH) release.10 A 1994 review details several possible 
pathophysiological relationships between menstruation and insulin-dependent diabetes, citing the 
impact of insulin and insulin-like growth factor-1 (IGF-1) in hormone synthesis and overall 
gonadal physiology.10 Ovarian function has also been shown to not be significantly affected by 
diabetes in human.10 Possible disturbances in ovarian function (such as ovarian atrophy) have 
been observed in diabetic animals, and progesterone production has been restored through 
controlled dosing with insulin.10 The authors note, however, that “while hyperandrogenaemia 
may occur in women with [insulin-dependent diabetes mellitus], it is not typically a significant 
factor responsible for anovulation.”10 The authors also found conflicting evidence of GnRH-
stimulated luteinizing hormone release due to “different methods of patient selection in various 
cited studies.”10 The primary physiological relationship of interest posited by the authors deals 
with hypothalamic function, noting a possible interruption in hypothalamic function and GnRH-
release “in women with poorly controlled diabetes mellitus” while acknowledging that the exact 
reason for this is unclear.10   
 A 1984 study sought to determine the effect of diabetes on age at menarche among a 
group of 211 adolescents between 9 and 25 years of age.11 The study found that no significant 
differences in menstrual cycle regularity exist between populations of non-diabetic and diabetic 
adolescents, but that age at menarche did seem delayed among adolescents with a diabetic onset 
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occurring during puberty rather than before.11 Like the 1994 study10, this study noted the likely 
disruption to be due to the influence the condition has on the hypothalamic-pituitary-gonadal 
axis maturation in females with a diabetic onset occurring during puberty, which results in a 
disruption in sexual maturation.11 It is worth noting, however, that this study suffers from 
significant selection bias, as the population only included white females within 20% of the ideal 
body weight, and is thus not generalizable to the general population. The inclusion of children 
who have not reached menarche may also create bias in this study.  
By contrast, a 2008 Italian study of similar design, also conducted solely on white 
females, found age at menarche to be delayed among patients with type 1 diabetes, and found no 
significant association with increased HbA1c levels or BMI.12 This study could also be 
influenced by significant selection bias and a lack of generalizability to the larger population. 
Similarly, a cross-sectional study in 2011 using NHANES data for a population of women 
between the ages of 12 and 24 found that “the age of menarche in adolescent females with 
premenarchal presentation of [type 1 diabetes mellitus] continues to be delayed.”13 This study 
also found that poor metabolic control (as shown by the significant negative correlation found 
among women with a higher BMI than women with a lower BMI regarding age at menarche) 
could play an important role in age at menarche.13  
A 2015 study, however, using self-reported answers to a questionnaire for a group of 
women over age 18, found no significant difference in age at menarche between women with 
type 1 diabetes and the control group, while also failing to find any significant differences in 
menstrual cycle irregularities between the groups (approximately 33.2% overall for type 1 
diabetics of all ages compared to approximately 30.2% in the control group, with a p-value of 
0.2).14 
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A 1992 Danish study sought to characterize 570 women between ages 18 and 49 in a 
particular county based on menstrual cycle status, with diabetic cases ascertained using 
prescription records.15 The control group was recruited through a random selection process using 
the registration of persons living in the county at the Odense University Hospital.15 The 
researchers found a significant difference in all menstrual cycle irregularity categories analyzed 
(primary amenorrhea, secondary amenorrhea, and oligomenorrhea/polymenorrhea).15 Similarly, 
a 1995 study by Yeshaya and colleagues of 100 diabetic patients with a mean age of 22 years, 
found 32% of this population reporting menstrual disturbances during the observation period, 
though the observation period is never clearly defined within the context of the study.16 The 
primary conclusion by these authors is that menstrual disturbances are more frequent in patients 
with poorly controlled diabetes.16 These authors also cite possible hypothalamic-pituitary-
ovarian axis function being influenced by insulin, additionally noting that the impact of weight 
and body fat should not be overlooked.16   
A 2003 study limited to women with type 1 diabetes and comparing them to their non-
diabetic sisters and unrelated control subjects also found a significant increase in menstrual cycle 
irregularities among women with type 1 diabetes than the control groups.17 When analyzed by 
age category in the univariate model, however, the results shift to statistically different menstrual 
irregularities being found only among type 1 diabetic women under age 20 and between ages 20 
and 29, with no statistically different results found in the two other age categories (30-39 years 
and 40-49 years).17 These results were echoed in their final logistic regression models, though 
the only results provided by the authors are odds ratios for women with type 1 diabetes, making 
further interpretation of the authors’ results difficult.17 The study also collapses younger women 
into one category, women less than 20 years of age.17 
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Utilizing HbA1c levels to determine adolescents’ (age 12 to 18) diabetic control, a 2010 
age-matched case-control study conducted in Greece found that both the incidence and odds of 
oligomenorrhea were significantly increased among women with type 1 diabetes than the 
controls (28.4% among the women with type 1 diabetes, compared to the 5.5% among the 
controls).18 This study showed an increased prevalence of menstrual irregularities among 
adolescents with type 1 diabetes.19 A similar 2010 study conducted in Santiago, Chile found that 
menstrual irregularities are common among adolescents, but “menstrual irregularities become 
more severe with poor metabolic control.”20 In this prospective study, the patients, all of whom 
had reached menarche and were under age 19, were asked to self-report days of menstrual cycles 
using a calendar which the patients were to highlight and, as in the Greek study18, HbA1c levels 
were utilized to determine the extent of diabetic control.20 However, bias cannot be excluded in 
this result, as the authors note that the control group was contacted monthly by telephone to fill 
out their calendars, while the group of girls with type 1 diabetes had their menstrual cycles 
recorded monthly at the hospital.20 
 Many studies also highlighted physical symptoms occurring alongside diabetes and 
irregular menstruation, particularly in regards to hyperandrogenism. The aforementioned 2015 
study found no significant differences in self-reporting of hirsutism between the women with 
type 1 diabetes and the control group, with 38% of women with type 1 diabetes compared to 
43% of controls.14 In 2012, a cross-sectional study in France examined the relationship between 
hirsutism and menstrual irregularities in girls with either obesity or type 1 diabetes.21 This study 
found significantly higher results of menstrual irregularities and symptoms of hyperandrogenism 
among women with elevated body mass indexes (BMIs) than among women with type 1 
diabetes.21 Another 2012 study giving an overview of the reproductive characteristics of women 
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with type 1 diabetes in Chile found that between “20-30% of the young adult women with [type 
1 diabetes]” displayed symptoms of excess androgen, which was higher than the Chilean general 
population (3%) and the Spanish general population (7.1%).22 The authors also found an 
increased prevalence of polycystic ovarian syndrome (PCOS) in women in Chile and Spain with 
type 1 diabetes: among the Chilean women with type 1 diabetes, the observed prevalence was 
12%, while the Spanish women with type 1 diabetes had an observed prevalence of 18.8%), 
compared to the prevalence in the general Spanish population, which lingers at approximately 
6.5%.22 Several of these studies note the relationship between irregular menstruation, insulin 
resistance, and excess androgens converging in another common endocrine disorder: PCOS.22-23 
PCOS is a disease impacting a large population of women, the exact extent of which is hard to 
determine due to lack of surveillance on the disease. Various estimates placed the number of 
women impacted by the disease anywhere between 4% and 12%.24-26  PCOS is a disease 
hallmarked, in part, by the presence of insulin resistance and the oligomenorrhea or amenorrhea, 
though these characteristics are not necessary for the diagnosis of the disease.26,27 This condition 
could also give significant insight into the exact mechanistic relationship between diabetes and 
menstrual cycle dysfunction, though further research is needed to determine the exact extent to 
which the conditions are related. 
Finally, there is some indication that menstruation also affects diabetes. In a 1977 study, 
using interviews by physicians on patients admitted to care for ketoacidosis from January 1974 
to June 1976, the researchers sought to uncover changes in insulin dosing and dietary habits in or 
around the patients’ menstrual cycles.28 The authors found a significant difference in diabetic 
control, particularly in regards to hyperglycemia near or during the time of menstruation among 
the women questioned by the doctors, though a significant volume of unacknowledged recall 
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bias may be affecting the overall results of the study.28 A 1998 study of Pima Indian women also 
found that the prevalence of type 2 diabetes was higher among women who had reported 
menstrual cycle irregularities (at 33% compared to 24% in the controls).23 
 
METHODS 
 A cross-sectional study design was created using data from the Kentucky Women’s 
Health Registry (KWHR), obtained from years 2006 to 2014, contributing an initial population 
of 52,020 de-identified observations with 16,645 unique participants. The data was limited to 
years in which both pregnancy and breastfeeding data was available (2009 to 2014) and limited 
to the first observation from each individual in the study based on the unique ID variable 
assigned to them by KWHR. This created a population of 38,570 subjects, consisting of 13,632 
unique participants. Women who were unable to menstruate due to self-reported conditions were 
excluded from the analysis; these populations included women over age 45 (considered the 
average age for perimenopausal women29), women who reported that they had been pregnant or 
breastfeeding within the past year (including women who suffered from ectopic pregnancies), 
women who had undergone a hysterectomy, and women who had both ovaries removed. 
Variables were not available for other medical conditions that could result in amenorrhea. Age 
was used as a proxy for menopause status, despite the availability of menopause data in KWHR, 
because of the limitations of the menopause outcomes data within the survey (C. Brancato, email 
correspondence, December 7, 2016). After the restriction of the data to the eligible population, 
4,256 participants remained in the analysis. The University of Kentucky Institutional Review 
Board (IRB) approved all research activities conducted in the original KWHR. No IRB approval 
was required for this secondary analysis of de-identified data.  
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Menstrual Cycles 
A dichotomous variable for self-reported menstrual cycle irregularity was utilized in the 
analysis, designating the participants’ responses to the survey question “During the past year, 
have you experienced any of the following?” in which irregular menstrual cycles was an option 
for response. The referent group for the analysis was women indicating no menstrual cycle 
irregularities. Observations in which data was missing for this question was excluded from the 
population. A variable was available regarding length of cycle, but was not utilized due to the 
potential for misclassification bias based on the levels of the variable, which included options for 
within the past 2 months, between 2 months to 1 year, between 1-3 years, between 3-5 years, 
more than 5 years ago, and never had a menstrual cycle. 
 
Diabetes 
 The diabetes variable included several categories of diabetes subtypes. A dichotomous 
variable for diabetes status was created, but the subtype variable with multiple categories was 
also utilized in the analysis because of the uniqueness in identifying not only different types of 
diabetes, but also different treatments. Diabetes was measured based on self-reported data from 
the survey responses, and included information on whether an observation was an insulin 
resistant or glucose resistant diabetic or pre-diabetic, a type I diabetic, a type II diabetic 
controlling the condition through diet only, a type II diabetic controlled by oral pills only, a type 
II diabetic taking insulin, a type II diabetic using both oral pills and insulin, unknown type of 
diabetes, and non-diabetic. The referent group for this population was women reporting no 
diabetes. 
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Confounders 
 Confounders considered for this analysis were age, weight, race and ethnicity, smoking 
status, type of health insurance and education level (used as a proxy for socioeconomic status), 
activity level, general health status, current stress level, problems controlling worry, excessive 
anxiety and worry, gynecological conditions such as polycystic ovarian syndrome and 
endometriosis, hormone therapy usage, and whether a subject was currently trying to lose 
weight. These confounders were measured via self-reported status. With the exception of age and 
weight, the variables analyzed were dichotomous. Many of the analyzed confounders were also 
included in similar analyses, in particular the 1992 Danish study15 and the 1998 Pima Indian 
study23. These confounders were chosen based on their relation to menstrual cycle irregularities, 
and were examined within the analysis for association with diabetes. 
 Age, weight, race and ethnicity, smoking status, and the socioeconomic status proxy, type 
of health insurance and education level, are basic demographic characteristics examined for 
relation to both diabetes and menstrual cycle irregularities. An insurance variable was created 
using the dichotomous variables provided in the dataset, in which the data was categorized from 
federal and state issued insurance levels (Medicare or Medicaid) to private insurance. A race 
variable was also created, utilizing the dichotomous race variables and the variable for primary 
race in instances where more than one race was identified by the participant. A participant was 
categorized in a race category if they marked only one race in the dichotomous variable level or 
identified a primary race in the leveled variable. The creation of this variable resulted in 4 
observations lost from the study, as not all participants identified a primary race. BMI was 
utilized over the weight variable to account for theoretical adiposity and weight distribution.31 
Weight was assessed as a potential effect modifier.12, 15, 30 A categorical variable for BMI was 
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created based on WHO standards: a BMI over 25 was considered overweight, while a BMI under 
18.5 was considered underweight.30-33 
 Activity level, current stress level, problems controlling worry, excessive anxiety and 
worry, and whether a woman was currently trying to lose weight all are known to impact 
menstrual cycle regularity. General health status, other gynecological conditions, and hormone 
usage were considered because of their relationship with menstrual cycle regularity, since, as 
noted earlier, menstrual cycle regularity is often used as a proxy for overall gynecological health.  
 Data was available for several different types of birth control currently being utilized by 
the women in the survey, including tubal ligation, emergency contraceptives, Implanon, Norplant 
implants, Depo Provera, Mirena/Paragard, birth control patches, and birth control pills. A new 
variable was created, indicating whether the method of birth control was likely to provoke 
regular menstrual cycles (birth control pills and birth control patches), unlikely to impact 
menstrual cycles (tubal ligation34, emergency contraceptives35, and Norplant implants36), or 
likely to eliminate menstrual cycles (Mirena/Paragard37, Implanon38, and Depo Provera39). 
Information on other birth control methods, such as Nuvaring, was not available for analysis. 
This multi-leveled variable was utilized for analysis over the individual dichotomous variables 
for each of the birth control variable due to small numbers in each of the dichotomous variables. 
Hormone usage was also combined into a dichotomous variable, due to small numbers in the 
cells for the individual dichotomous variables. 
 
Statistical Analyses 
 Basic statistical descriptors of the data were obtained using frequency analyses to analyze 
the data based on menstrual cycle status. Analyses using the dichotomous variable for menstrual 
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cycle irregularities and the dichotomous variable for diabetes were conducted to create frequency 
tables to characterize the data and distinguish differences between the two variables. 
Confounders were assessed using chi-square analyses for categorical variables and a Student’s t-
test for continuous variables to examine the strength of the factor in relation to both diabetes and 
menstrual cycle irregularities.  Bivariate analyses were conducted on the data to determine the 
odds of menstrual cycle irregularities based on diabetes status and the confounders. The 
Breslow-Day test was utilized to examine potential effect modifiers. Logistic regression analyses 
were then conducted to test the hypothesis that diabetes is associated with menstrual cycle 
irregularities. Sensitivity analyses were conducted using stratified logistic regression analyses to 
examine associations of interest. Statistical analyses for this study were conducted using SAS 
v9.4. A significance level of 0.05 was used. 
 
RESULTS 
 After exclusions, 4,256 unique participants remained in the dataset for analysis. This 
overall sample had a mean age of 33.63 (SD 6.74), with 27.68% (n=1,178) reporting menstrual 
cycle irregularities. Of the total sample, 5.92% (n=252) reported having been diagnosed with 
diabetes. Table 1 displays demographic information. No differences were observed between with 
and without menstrual cycle irregularities by age, race, or ethnicity, and the distribution of 
education was similar between groups. The women in the study population were overwhelmingly 
white and non-Hispanic.  
Insurance status and education level were, together, utilized as a proxy for socioeconomic 
status, and both were showing to be highly significantly associated with menstrual cycle 
irregularities. Women reporting menstrual cycle irregularities had a larger prevalence of no 
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insurance than women reporting no menstrual cycle irregularities (OR=1.56). Women reporting 
menstrual cycle irregularities also had lower education in the overall sample than women 
reporting no menstrual cycle irregularities. There was also a larger number of women reporting 
smoking more than 100 cigarettes in their lifetime (ever smoking) among the women reporting 
the presence of menstrual cycle irregularities than among women reporting no menstrual cycle 
irregularities. 
Table 1. Demographic characteristics of Kentucky Women’s Health Registry participants, 2009-
2014, stratified by menstrual cycle regularity status (N = 4,256) 
Characteristic Menstrual Cycle 
Irregularities 
Present  
n = 1,178 
Menstrual Cycle 
Irregularities 
Absent 
n = 3,078 
Odds  
Ratio 
95% 
Confidence 
Interval 
Age, mean(SD) 33.22 (6.79) 33.79 (6.72) 0.99 (0.98, 0.999) 
Education Level, n (%)     
High school diploma or less 51 (4.34) 132 (4.29) 1.15 (0.82, 1.60) 
GED 16 (1.36) 33 (1.07) 1.44 (0.79, 2.63) 
Vocational or training certificate 45 (3.83) 100 (3.25) 1.34 (0.93, 1.92) 
Some college or associate’s degree 345 (29.34) 678 (22.05) 1.51 (1.29, 1.77) 
Bachelor’s degree or higher 690 (58.67) 2,048 (66.60) Ref -- 
Other 29 (2.47) 84 (2.73) 1.03 (0.67, 1.58) 
Missing 2 3   
Race, n (%)     
White 1,118 (95.31) 2,879 (94.39) Ref -- 
Black/African-American 34 (2.90) 122 (4.00) 0.72 (0.49, 1.06) 
Asian 8 (0.68) 26 (0.85) 0.79 (0.36, 1.76) 
American Indian or Alaska Native 5 (0.43) 8 (0.26) 1.61 (0.53, 4.93) 
Native Hawaiian or Pacific Islander 2 (0.17) 4 (0.13) 1.288 (0.24, 7.04) 
Other race 6 (0.51) 11 (0.36) 1.41 (0.52, 3.81) 
Missing 5 28   
Ethnicity, n (%)     
Hispanic 10 (0.87) 25 (0.83) 1.04 (0.50, 2.17) 
Not Hispanic 1,145 (99.13) 2,972 (99.17) Ref -- 
Missing 23 81   
BMI, mean (SD) 29.09 (8.62) 27.50 (7.14) 1.03 (1.02, 1.04) 
Missing 37 101   
BMI Category, n (%)     
Underweight 24 (2.10) 49 (1.65) 1.44 (0.88, 2.38) 
Normal weight 446 (39.09) 1,315 (44.17) Ref -- 
Overweight 671 (58.81) 1,613 (54.18) 1.23 (1.07, 1.41) 
Missing 37 101   
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Table 1. Continued. 
Insurance, n (%)     
Medicare/Medicaid 41 (3.51) 72 (2.35) 1.61 (1.09, 2.38) 
VA/Tricare 22 (1.88) 36 (1.18) 1.73 (1.01, 2.96) 
Private insurance 945 (80.91) 2,676 (87.45) Ref -- 
Uninsured 147 (12.59) 247 (8.07) 1.69 (1.36, 2.10) 
Unknown 13 (1.11) 29 (0.95) 1.27 (0.66, 2.45) 
Missing 10 18   
Smoking status, n (%)     
Never smoker 758 (64.68) 2,115 (69.30) Ref -- 
Every day smoker 144 (12.29) 266 (8.72) 1.51 (1.21, 1.88) 
Some days smoker 54 (4.61) 128 (4.19) 1.17 (0.85, 1.64) 
Used to smoke, but quit 216 (18.43) 543 (17.79) 1.11 (0.93, 1.33) 
Missing 6 26   
Key demographic figures for the Kentucky Women’s Health Registry population, stratified by menstrual cycle 
regularity status, represent crude associations for age, BMI both as a continuous variable and a categorical 
variable, education, insurance status, race and ethnicity, and smoking status. Of these variables, age, BMI (both 
continuous and categorical), and insurance status were significant. 
 
 
Of the women reporting presence of menstrual cycle irregularities, 9.25% (n=109) of 
women reported diabetes, compared to 4.65% (n=143) of women reporting no menstrual cycle 
irregularities (p-value <.0001, OR=2.09) (Table 2). Among the women reporting diabetes for 
both groups, insulin resistant, glucose intolerant, or pre-diabetic women held the largest 
percentage of observations (4.07% among women reporting menstrual cycle irregularities and 
2.08% among women reporting no menstrual cycle irregularities). Type II diabetic women taking 
insulin alone had the highest odds of self-reporting menstrual cycle irregularities, with these 
women having odds 2.74 times higher than non-diabetic women.   
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Table 2. Crude association between menstrual cycle irregularities and diabetes, Kentucky 
Women’s Health Registry, 2009-2014. 
Variable Menstrual Cycle 
Irregularities 
Present  
n = 1,178 
Menstrual Cycle 
Irregularities 
Absent 
n = 3,078 
Odds  
Ratio 
95% 
Confidence 
Interval 
Diabetes, n(%) 109 (9.25) 143 (4.65) 2.09 (1.62, 2.72) 
Diabetes Subtypes, n (%)     
Insulin resistant, glucose 
intolerant, or pre-diabetic 
48 (4.07) 64 (2.08) 2.06 (1.41, 3.02) 
Type I diabetic 9 (0.76) 16 (0.52) 1.55 (0.68, 3.51) 
Type II diabetic, diet only 11 (0.93) 12 (0.39) 2.52 (1.11, 5.72) 
Type II diabetic, oral pills 
only 
26 (2.21) 33 (1.07) 2.16 (1.29, 3.64) 
Type II diabetic, insulin only 8 (0.68) 8 (0.26) 2.74 (1.03, 7.33) 
Type II diabetic, oral pills 
and insulin 
3 (0.24) 5 (0.16) 1.65 (0.39, 6.91) 
Unknown diabetic 4 (0.34) 5 (0.16) 2.20 (0.59, 8.20) 
Non-diabetic 1069 (90.75) 2935 (95.35) Ref -- 
Diabetes is shown to be significantly associated with menstrual cycle irregularity status in these frequency analyses 
with bivariate odds ratios. 
 
 As noted earlier, menstrual cycle irregularities are often indicative of other gynecological 
issues, and, as such, may be important potential confounders.1-3 Table 3 presents self-reported 
diagnoses of these conditions stratified by menstrual cycle regularity status. Many of these 
variables, unsurprisingly, showed significant differences among the groups. In each case, the 
conditions are reported by women with menstrual cycle irregularities by a ratio of as much as 
two to three times higher than women reporting no menstrual cycle irregularities. The 
constructed birth control variable showed significant differences, with the largest differences 
being shown in birth control likely to provoke menstrual cycles. Curiously, hormone usage was 
shown to have no significant differences among the strata, most likely due to a large percentage 
of the data being missing (approximately 46% of the observations) and small numbers in each of 
the cells. 
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Table 3. Diagnosed gynecological conditions of Kentucky Women’s Health Registry 
participants, 2009-2014, stratified by menstrual cycle regularity status (N = 4,256). 
Variable Menstrual Cycle 
Irregularities 
Present  
n = 1,178 
Menstrual Cycle 
Irregularities 
Absent 
n = 3,078 
Odds 
Ratio 
95% 
Confidence 
Interval 
Abnormal Pap Smear, n (%) 370 (31.54) 855 (27.83) 1.20 (1.03, 1.38) 
Missing 5 6   
Endometriosis, n (%) 110 (9.38) 235 (7.65) 1.25 (0.99, 1.58) 
Missing 5 6   
Endometriosis Removed, n (%) 34 (5.02) 82 (4.90) 1.03 (0.68, 1.55) 
Missing 501 1,403   
Fibroid Diagnosis, n (%) 81 (6.91) 164 (5.34) 1.32 (0.999, 1.73) 
Missing 5 6   
Frequent Vaginal Infections, 
n(%) 
49 (4.16) 84 (2.73) 1.55 (1.08, 2.22) 
Missing 5 6   
Frequent Yeast Infections, n (%) 113 (9.63) 229 (7.45) 1.32 (1.04, 1.68) 
Missing 5 6   
General pelvic pain, n (%) 166 (14.09) 223 (7.24) 2.10 (1.70, 2.60) 
Infertility, n (%) 105 (8.95) 141 (4.59) 2.05 (1.57, 2.66) 
Missing S5 6   
Low sex drive, n (%) 529 (44.91) 1,133 (36.81) 1.40 (1.22, 1.60) 
Painful or prolonged menstrual 
cycles, n (%) 
709 (60.19) 1,455 (47.27) 1.69 (1.47, 1.93) 
Pain with intercourse, n (%) 365 (22.50) 425 (13.81) 1.81 (1.53, 2.15) 
Pelvic adhesions, n (%) 17 (1.45) 20 (0.65) 2.25 (1.17, 4.30) 
Missing 5 6   
PMS/PMDD, n (%)  145 (12.36) 292 (9.51) 1.34 (1.09, 1.66) 
Missing 5 6   
Polycystic ovarian syndrome, n 
(%) 
144 (12.28) 160 (5.21) 2.55 (2.01, 3.23) 
Missing 5 6   
Prolonged/heavy menses, n (%) 388 (32.94) 601 (19.53) 2.03 (1.74, 2.35) 
One ovary removed, n (%) 17 (1.45) 49 (1.60) 0.91 (0.52, 1.58) 
Missing 4 8   
Severe hot flashes, n (%) 118 (10.02) 136 (4.42) 2.41 (1.86, 3.11) 
Uterine prolapse, n (%) 3 (0.25) 11 (0.36) 0.71 (0.20, 2.56) 
Missing 5 6   
Uterine polyps, n (%) 20 (1.71) 30 (0.98) 1.76 (1.00, 3.11) 
Missing 5 6   
Vaginal dryness, n (%) 241 (20.46) 453 (14.72) 1.49 (1.25, 1.77) 
Vulvar pain, n (%) 86 (7.30) 122 (3.96) 1.91 (1.44, 2.54) 
Other diagnosed gynecological 
conditions, n (%) 
42 (3.58) 60 (1.95) 1.87 (1.25, 2.78) 
Missing 5 6   
Birth control level, n (%) †     
No birth control 587 (53.31) 1,588 (53.72) Ref -- 
Likely to provoke menstruation 305 (27.80) 1,011 (34.20) 0.82 (0.70, 0.96) 
Likely to eliminate menstruation 157 (14.31) 227 (7.68) 1.87 (1.50, 2.34) 
Not likely to impact menstruation 48 (4.38) 130 (4.40) 1.00 (0.71, 1.41) 
Missing 81 122   
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Table 3. Continued. 
Hormone usage, n (%)* 21 (3.27) 35 (2.14) 1.54 (0.89, 2.67) 
Missing 535 1,443   
How Long Between Cycles, n (%)     
Within past 2 months 997 (85.00) 2821 (92.31) Ref -- 
Between 2 months to 1 year 120 (10.23) 78 (2.55) 4.35 (3.24, 5.84) 
Between 1-3 years 43 (3.67) 77 (2.52) 1.58 (1.08, 2.31) 
Between 3-5 years ago 9 (0.77) 44 (1.44) 0.58 (0.28, 1.19) 
More than 5 years ago 4 (0.34) 36 (1.18) 0.32 (0.11, 0.89) 
Missing 5 22   
† Leveled birth control variable was created using dichotomous variables for different methods of birth control. 
Self-reported use of birth control pills or birth control patches was assigned to the “likely to provoke menstruation” 
category; self-reported use of Mirena or Paragard, Implanon, or Depo Provera was assigned to the “likely to 
eliminate menstruation” category; and self-reported tubal ligation and emergency contraceptive usage was 
assigned to the “not likely to impact menstruation” category. No women reported use of Norplant implants, and so 
the variable was not included in this leveled variable. 
* Hormone usage refers to any reported use of a hormone, including hormones designed to treat infertility. 
 
 Activity level, general health status, stress level, worry level, and anxiety levels were also 
stratified by menstrual cycle status (Table 4). Women reporting menstrual cycle irregularities 
reported lower levels of activity, worse health, and more stress than women reporting no 
menstrual cycle irregularities; these women also reported larger percentages of uncontrolled 
worry or excessive anxiety, as well as larger percentages of post-traumatic stress disorder 
(PTSD). Women self-reporting menstrual cycle irregularities had 3.84 times the odds of 
reporting poor vs. excellent overall health status compared to women reporting no menstrual 
cycle irregularities.  
Table 4. Psychosocial health conditions of Kentucky Women’s Health Registry participants, 
2009-2014, stratified by menstrual cycle regularity status (N = 4,256). 
Variable Menstrual Cycle 
Irregularities 
Present  
n = 1,178 
Menstrual 
Cycle 
Irregularities 
Absent 
n = 3,078 
Odds 
Ratios 
95% 
Confidence 
Interval 
Level of physical activity, n (%)     
Sedentary 290 (24.74) 607 (19.77) 1.58 (1.26, 1.97) 
Moderately active 719 (61.35) 1,929 (62.72) 1.23 (1.01, 1.50) 
Very active 163 (13.91) 538 (17.52) Ref -- 
Missing 6 7   
General health condition, n (%)     
Excellent 149 (12.66) 551 (17.91) Ref -- 
Very good 453 (38.49) 1,400 (45.50) 1.20 (0.97, 1.48) 
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Table 4. Continued. 
Good 401 (34.07) 880 (28.60) 1.69 (1.36, 2.09) 
Fair 147 (12.49) 220 (7.15) 2.47 (1.87, 3.26) 
Poor 27 (2.29) 26 (0.84) 3.84 (2.18, 6.78) 
Missing 1 1   
Current stress level, n (%)     
Small 148 (12.57) 550 (17.91) Ref -- 
Moderate 545 (46.30) 1,584 (51.58) 1.28 (1.04, 1.57) 
Large 361 (30.67) 749 (24.39) 1.79 (1.44, 2.23) 
Overwhelming 123 (10.45) 188 (6.12) 2.43 (1.82, 3.25) 
Missing 1 7   
Problems controlling worry, n (%)     
Yes, in the past 12 months 416 (45.61) 849 (39.23) 1.32 (1.08, 1.62) 
Yes, in my lifetime 309 (33.88) 810 (37.43) 1.03 (0.83, 1.28) 
No 187 (20.50) 505 (23.34) Ref -- 
Missing 266 914   
Excessive anxiety or worry, n(%)     
Yes, in the past 12 months 558 (47.65) 1,169 (38.12) 1.65 (1.40, 1.96) 
Yes, in my lifetime 347 (29.63) 976 (31.82) 1.23 (1.03, 1.48) 
No 266 (22.72) 922 (30.06) Ref -- 
Missing 7 11   
PTSD, n(%) 348 (29.82) 680 (22.27) 1.48 (1.27, 1.72) 
Missing 11 25   
Trying to Lose Weight, n(%) 790 (67.69) 1,951 (63.76) 1.19 (1.03, 1.37) 
Missing 11 18   
Crude associations for psychosocial health factors with menstrual cycle regularity status. Of the variables analyzed, 
level of physical activity, general health condition, current stress level, excessive anxiety or worry, PTSD, and trying 
to lose weight were shown to be significantly associated with menstrual cycle regularity status. 
  
 
To further assess potential confounders, the population was then stratified based on self-
reported diabetes status. Variables that showed significant associations with menstrual 
dysregulation were analyzed for associations with diabetes (Table 5). Diabetic women in this 
analysis were shown to have an average age significantly older than non-diabetic women (36.16 
for diabetic women compared to 33.47 for non-diabetic women). Women with diabetes also had 
a larger percentage with a BMI classifying them as overweight than non-diabetic women.  
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Table 5. Demographic and psychosocial factors of the Kentucky Women’s Health Registry 
participants, 2009-2014, stratified by dichotomous diabetes status (N = 4,256). 
Variable Diabetic Status 
(All Types) 
n = 252 
Non-Diabetic 
Status 
n = 4013 
Odds Ratio 95% 
Confidence 
Interval 
Irregular menstrual cycles, 
n(%) 
109 (43.25) 1,069 (26.70) 2.09 (1.62, 2.71) 
How Long Between Cycles, 
n (%) 
    
Within past 2 months 211 (84.06) 3,607 (90.67) Ref -- 
Between 2 months to 1 year 22 (8.76) 176 (4.42) 2.14 (1.34, 3.40) 
Between 1-3 years 11 (4.38) 109 (2.74) 1.73 (0.91, 3.26) 
Between 3-5 years 5 (1.99) 48 (1.21) 1.78 (0.70, 4.5) 
More than 5 years  2 (0.80) 38 (0.96) 0.90 (0.22, 3.76) 
Missing 1 26   
Age, mean(SD) 36.16 (6.25) 33.47 (6.47) 1.06 (1.04, 1.09) 
BMI, mean(SD) 35.75 (9.31) 27.46 (7.22) 1.03 (1.02, 1.04) 
BMI Category, n (%)     
Underweight 1 (0.42) 72 (1.86) 0.96 (0.13, 7.22) 
Normal weight 25 (10.46) 1,736 (44.75) Ref -- 
Overweight 213 (89.12) 2,071 (53.39) 7.14 (4.70, 10.86) 
Missing 13 125   
Insurance, n (%)     
Medicare/Medicaid 16 (6.35) 97 (2.44) 2.88 (1.67, 4.99) 
VA/Tricare 2 (0.79) 56 (1.41) 0.62 (0.15, 2.58) 
Private insurance 196 (77.78) 3,425 (86.14) Ref -- 
Uninsured 37 (14.68) 357 (8.98) 1.81 (1.25, 2.62) 
Unknown 1 (0.40) 41 (1.03) 0.43 (0.06, 3.12) 
Missing 0 28   
Education Level, n (%)     
High school diploma or less 15 (5.95) 168 (4.20) 1.87 (1.07, 3.26) 
GED 4 (1.59) 45 (1.13) 1.86 (0.66, 5.25) 
Vocational or training 
certificate 
16 (6.35) 129 (3.23) 2.59 (1.50, 4.49) 
Some college or associate’s 
degree 
84 (33.33) 939 (23.48) 1.87 (1.40, 2.49) 
Bachelor’s degree or higher 125 (49.60) 2,613 (65.34) Ref -- 
Other 8 (3.17) 105 (2.63) 1.59 (0.76, 3.34) 
Missing 0 5   
Smoking Status, n(%)     
Never smoker 164 (65.08) 2,709 (68.20) Ref -- 
Every day smoker 28 (11.11) 382 (9.62) 1.21 (0.80, 1.83) 
Some days smoker 10 (3.97) 172 (4.33) 0.96 (0.50, 1.85) 
Used to smoke, but quit 50 (19.84) 709 (17.85) 1.17 (0.84, 1.62) 
Missing 0 32   
Crude associations for associations for demographic and psychosocial health factors stratified by dichotomous 
diabetes status. For these variables, age, BMI, and education were shown to be significantly associated with 
diabetes. 
 
 Table 6 stratified diagnosed gynecological conditions by diabetes status, based on the 
variables showing significant differences in menstrual cycle stratification from Table 3. From 
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these analyses, abnormal pap smears, frequent vaginal infections, low sex drive, pain with 
intercourse, pelvic adhesions, and uterine polyps showed no significant differences between the 
women with and without diabetes. Many of the significant associations shown in this analysis 
could be due, in part, to low numbers in the diabetic strata. Fascinatingly, from Table 3, women 
self-reporting menstrual cycle irregularities had 2.55 times the odds of reporting a PCOS 
diagnosis compared to women reporting no menstrual cycle irregularities, while diabetic women 
had 9.18 times the odds of reporting a PCOS diagnosis compared to non-diabetic women. 
However, many of the associations, particularly with gynecological conditions such as polycystic 
ovarian syndrome, could be explained through a relationship between these conditions and 
adiposity. 
Table 6. Diagnosed gynecological conditions of the Kentucky Women’s Health Registry, 
stratified by diabetes status. (N = 4,256) 
Variable Diabetic Status 
(All Types) 
n = 252 
Non-Diabetic 
Status 
n = 4013 
Odds Ratio 95% 
Confidence 
Interval 
Abnormal pap smear, n(%) 65 (25.79) 1,160 (29.05) 0.85 (0.64, 1.14) 
Missing 0 11   
Frequent vaginal infections, 
n(%) 
11 (4.37) 122 (3.06) 1.45 (0.77, 2.72) 
Missing 0 11   
Frequent yeast infections, 
n(%) 
45 (17.86) 297 (7.44) 2.71 (1.92, 3.81) 
Missing 0 11   
General pelvic pain, n(%) 43 (17.06) 346 (8.64) 2.18 (1.54, 3.08) 
Infertility, n(%) 34 (13.49) 212 (5.31) 2.78 (1.89, 4.10) 
Missing 0 11   
Low sex drive, n(%) 104 (41.27) 1,558 (38.91) 1.10 (0.85, 1.43) 
Painful or prolonged 
menstrual cycles, n(%) 
154 (61.11) 2,010 (50.20) 1.56 (1.20, 2.02) 
Pain with intercourse, n(%) 50 (19.84) 640 (15.98) 1.30 (0.94, 1.79) 
Pelvic adhesions, n(%) 3 (1.19) 34 (0.85) 1.41 (0.43, 4.60) 
Missing 0 11   
PMS/PMDD, n(%)  44 (17.46) 393 (9.84) 1.94 (1.38, 2.73) 
Missing 0 11   
Polycystic ovarian 
syndrome, n(%) 
87 (34.52) 217 (5.43) 9.18 (6.84, 12.31) 
Missing 0 11   
Prolonged/heavy menses, 
n(%) 
97 (38.49) 892 (22.28) 2.18 (1.68, 2.84) 
Severe hot flashes, n(%) 32 (12.70) 222 (5.54) 2.48 (1.67, 3.68) 
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Table 6. Continued. 
Uterine polyps, n(%) 4 (1.59) 46 (1.15)   
Missing 0 11   
Vaginal dryness, n(%) 55 (21.83) 639 (15.96) 1.47 (1.08, 2.01) 
Vulvar pain, n(%) 19 (7.54) 189 (4.72) 1.65 (1.01, 2.69) 
Other diagnosed 
gynecological conditions, 
n(%) 
11 (4.37) 91 (2.28) 1.96 (1.03, 3.71) 
Missing 0 11   
Birth control level, n (%)†     
No birth control 133 (58.59) 2,042 (53.37) Ref -- 
Likely to provoke 
menstruation 
54 (23.79) 1,262 (32.98) 0.66 (0.48, 0.91) 
Likely to eliminate 
menstruation 
17 (7.49) 367 (9.59) 0.71 (0.42, 1.19) 
Not likely to impact 
menstruation 
23 (10.13) 155 (4.05) 2.28 (1.42, 3.65) 
Missing 25 178   
† Leveled birth control variable was created using dichotomous variables for different methods of birth control. 
Self-reported use of birth control pills or birth control patches was assigned to the “likely to provoke menstruation” 
category; self-reported use of Mirena or Paragard, Implanon, or Depo Provera was assigned to the “likely to 
eliminate menstruation” category; and self-reported tubal ligation and emergency contraceptive usage was 
assigned to the “not likely to impact menstruation” category. No women reported use of Norplant implants, and so 
the variable was not included in this leveled variable. 
 
 Significant non-gynecological conditions from the analysis for the population stratified 
based on diabetes status, as shown in Table 7. Diabetic women were more likely to report 
themselves as being less active than non-diabetic women and in a worse general health 
condition, with odds of 15.13 for self-reporting fair overall health status and 35.48 for self-
reporting poor overall health status. They also reported higher levels of stress, more uncontrolled 
worry, more excessive anxiety, and a larger percentage was trying to lose weight than among 
non-diabetic women. The significance of these variables could be due in part, again, to the 
relatively small number of diabetic women in the study population. 
Table 7. Non-gynecological conditions of the Kentucky Women’s Health Registry, stratified by 
diabetes status. (N = 4,256) 
Variable Diabetes 
(All Types) 
n = 252 
No Diabetes 
n = 4013 
Odds Ratio 95% 
Confidence 
Interval 
Level of activity, n (%)     
Sedentary 94 (37.30) 803 (20.12) 3.79 (2.34, 6.15) 
Moderately active 137 (54.37) 2,508 (62.84) 1.77 (1.11, 2.82) 
Very active 21 (8.33) 680 (17.04) Ref -- 
Missing 0 13   
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Table 7. Continued. 
General health condition, n (%)     
Excellent 10 (3.97) 690 (17.24) Ref -- 
Very good 50 (19.84) 1,803 (45.05) 1.91 (0.97, 3.80) 
Good 108 (42.86) 1,173 (29.31) 6.35 (3.30, 12.22) 
Fair 66 (26.19) 301 (7.52) 15.13 (7.67, 29.82) 
Poor 18 (7.14) 35 (0.85) 35.48 (15.25, 82.55) 
Missing 0 2   
Current stress level, n (%)     
Small 24 (9.52) 674 (16.87) Ref -- 
Moderate 112 (44.44) 2,017 (50.48) 1.56 (0.99, 2.44) 
Large 75 (29.76) 1,035 (25.90) 2.04 (1.27, 3.26) 
Overwhelming 41 (16.27) 270 (6.76) 4.27 (2.53, 7.20) 
Missing 0 8   
Problems controlling worry, n (%)     
Yes, in the past 12 months 106 (50.24) 1,159 (40.45) 1.89 (1.26, 2.83) 
Yes, in my lifetime 73 (34.60) 1,046 (36.51) 1.44 (0.94, 2.21) 
No 32 (15.17) 660 (23.04) Ref -- 
Missing 41 1,139   
Excessive anxiety or worry, n (%)     
Yes, in the past 12 months 134 (53.59) 1,593 (39.95) 2.14 (1.51, 3.02) 
Yes, in my lifetime 72 (28.69) 1,251 (31.38) 1.46 (0.999, 2.14) 
No 45 (17.93) 1,143 (28.67) Ref -- 
Missing 1 17   
PTSD, n(%) 72 (28.92) 956 (24.07) 1.28 (0.97, 1.70) 
Missing 3 33   
Trying to Lose Weight, n (%) 202 (80.48) 2,539 (63.86) 2.33 (1.70, 3.21) 
Missing 1 28   
Crude associations for non-gynecological factors stratified by diabetic status. Of the variables analyzed within this 
table, level of activity, general health condition, current stress level, and trying to lose weight was significantly 
associated with diabetes. 
 
Based on the results from these analyses, the factors included as confounders in this 
analysis were age, BMI, insurance status, education level, frequent yeast infections, general 
pelvic pain, infertility, painful menstruation, PMS/PMDD, polycystic ovarian syndrome, 
prolonged/heavy menses, severe hot flashes, vaginal dryness, vulvar pain, other diagnosed 
gynecological conditions, birth control level, level of activity, general health condition, current 
stress level, problems controlling worry, excessive anxiety or worry, and trying to lose weight. 
 
Effect Modification 
 The categorical BMI and birth control level variable were tested against diabetes and 
irregular menstrual cycles to measure effect modification. A Breslow-Day test was utilized to 
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test for significant differences between the odds ratios. The Breslow-Day test reported a p-value 
for the analysis stratified by BMI of 0.29 and, for the analysis stratified by birth control level, a 
p-value of 0.16. Based on these tests, no evidence of significant differences between odds ratios 
could be justified. The variables were utilized in the logistic regression model as confounders 
rather than effect modifiers. Cross-products were also run using the dichotomous diabetes 
variable to test for interactions between the variable of interest and the variables in the model. 
Overwhelmingly, the results of this analysis indicated no interactions, with the exception of a 
couple strata of the education variable. From this, and the results of the Breslow-Day test, we 
conclude there is not sufficient evidence of effect modification in the context of this analysis. 
 
Logistic Regression Analysis 
 Two logistic regression models were fitted to the data, first incorporating the 
dichotomous diabetes variable used throughout this analysis and then using the diabetes subtypes 
variable to gain further insight into the effect of menstrual cycle irregularity on diabetes given 
the confounders discovered. Table 8 shows the results of the logistic regression analysis utilizing 
the dichotomous diabetes variable. Significance is indicated in this table using a bold font. In this 
analysis, diabetes was not significantly associated with menstrual dysregulation. This could be 
due to the number of confounders assessed in the model, as well as multicollinearity resulting 
from several variables that are similar in nature. The adjusted odds ratio for diabetic women self-
reporting menstrual cycle regularities was 1.17 (CI 0.82 – 1.66), indicating greater odds of 
diabetic women self-reporting menstrual cycle irregularities. Very few of the assessed 
confounders showed significance in this model. 
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Table 8. Logistic regression analysis and adjusted odds ratios utilizing the dichotomous diabetes 
variable, Kentucky Women’s Health Registry, 2009-2014. 
Variable Beta Estimate Odds Ratio 95% CI Pr > ChiSq 
Diabetes Status 0.15 1.17 (0.82, 1.66) 0.39 
Age, 1-year -0.01 0.99 (0.97, 1.00) 0.04 
BMI Category     
Underweight 0.16 1.17 (0.59, 2.32) 0.65 
Normal Weight Ref -- -- -- 
Overweight -0.13 0.88 (0.71, 1.08) 0.21 
Insurance     
Medicare/Medicaid 0.07 1.07 (0.64, 1.79) 0.80 
VA/Tricare 0.50 1.65 (0.85, 3.18) 0.14 
Private Insurance Ref -- -- -- 
Uninsured 0.24 1.28 (0.95, 1.71) 0.10 
Unknown -0.004 1.00 (0.95, 1.71) 0.99 
Education Level     
High school 
diploma or less 
0.03 1.03 (0.64, 1.66) 0.90 
GED 0.01 1.01 (0.47, 2.16) 0.98 
Vocational or 
training certificate 
0.14 1.15 (0.71, 1.85) 0.58 
Some college or 
associate’s degree 
0.23 1.26 (1.02, 1.55) 0.03 
Bachelor’s degree 
or higher 
Ref -- -- -- 
Other 0.05 1.05 (0.60, 1.84) 0.86 
Level of Activity     
Sedentary 0.03 1.03 (0.76, 1.40) 0.85 
Moderately Active -0.03 0.97 (0.75, 1.26) 0.84 
Very Active Ref -- -- -- 
General Health 
Condition 
    
Excellent Ref -- -- -- 
Very Good 0.02 1.02 (0.76, 1.35) 0.92 
Good 0.20 1.22 (0.89, 1.67) 0.22 
Fair 0.34 1.40 (0.94, 2.10) 0.10 
Poor 0.54 1.71 (0.80, 3.68) 0.17 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate 0.12 1.12 (0.84, 1.51) 0.44 
Large 0.26 1.30 (0.95, 1.78) 0.11 
Overwhelming 0.42 1.52 (1.02, 2.26) 0.04 
Problems 
Controlling Worry 
    
Yes, in the past 12 
months 
-0.12 0.89 (0.67, 1.17) 0.39 
Yes, in my lifetime -0.12 0.89 (0.70, 1.13) 0.33 
No Ref -- -- -- 
Excessive Anxiety 
or Worry 
    
Yes, in the past 12 
months 
-0.13 0.88 (0.37, 2.08) 0.77 
Yes, in my lifetime -0.17 0.84 (0.36, 1.98) 0.70 
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Table 8. Continued. 
No Ref -- -- -- 
Trying to Lose 
Weight 
0.12 1.12 (0.92, 1.37) 0.25 
Frequent Yeast 
Infections 
-0.04 0.96 (0.71, 1.29) 0.79 
General Pelvic 
Pain 
0.22 1.25 (0.95, 1.64) 0.12 
Infertility 0.61 1.83 (1.28, 2.62) 0.0008 
Painful or 
Prolonged 
Menstrual Cycles 
0.27 1.31 (1.07, 1.59) 0.008 
PMS/PMDD 0.04 1.04 (0.80, 1.36) 0.75 
Polycystic Ovarian 
Syndrome 
0.52 1.68 (1.21, 2.35) 0.002 
Prolonged/Heavy 
Menses 
0.36 1.43 (1.16, 1.76) 0.0006 
Severe Hot Flashes 0.58 1.78 (1.28, 2.48) 0.0006 
Vaginal Dryness 0.26 1.30 (1.04, 1.62) 0.02 
Vulvar Pain 0.31 1.36 (0.95, 1.94) 0.09 
Other 
Gynecological 
Conditions 
0.31 1.37 (0.81, 2.30) 0.24 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.06 0.94 (0.77, 1.16) 0.56 
Likely to eliminate 
menstruation 
0.74 2.10 (1.58, 2.79) <.0001 
Not likely to impact 
menstruation 
-0.13 0.88 (0.58, 1.34) 0.55 
In this fully-adjusted logistic regression analysis model, diabetes failed to achieve statistical significance. Infertility, 
painful or prolonged menstrual cycles, PCOS, prolonged or heavy menses, severe hot flashes, and vaginal dryness 
managed to achieve statistical significance. 
 
 This analysis was then repeated utilizing the diabetes subtypes variable. The results of 
this analysis are shown in Table 9. Significance from this analysis are again indicated by bolded 
font. Type II diabetes controlled by diet alone was statistically significant in this model, with an 
odds ratio of 3.36 compared to non-diabetic women (p-value of 0.02). Overwhelming stress was 
shown to be statistically significant, increasing the odds of a woman reporting menstrual cycle 
irregularities 54% against a woman reporting a small level of stress. Infertility was also shown to 
be significant in this model, producing an odds ratio of 1.85. Finally, various variables indicating 
difficult menstrual cycles (heavy menstrual cycles and painful menstrual cycles) were shown to 
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be significant in the model. Collinearity could exist between these two variables, as both 
variables included the word “prolonged” in the survey question, though two very different 
symptoms were being targeted by the variables -- heavy menstrual cycles aims to account for a 
high volume of blood lost during a menstrual cycle while painful menstrual cycles aims to 
examine the level of pain incurred during a menstrual cycle.  
Table 9. Logistic regression analysis and adjusted odds ratios utilizing the expanded diabetes 
variable. 
Variable Beta Estimate Odds Ratio 95% CI Pr > ChiSq 
Diabetes Diagnosis   -- -- 
Insulin resistant, 
glucose intolerant, 
or pre-diabetic 
0.09 1.10 (0.67, 1.81) 0.71 
Type I Diabetic -0.28 0.75 (0.26, 2.22) 0.61 
Type II Diabetic, 
Diet Only 
1.21 3.36 (1.19, 9.47) 0.02 
Type II Diabetic, 
Oral Pills Only 
-0.04 0.96 (0.45, 2.09) 0.93 
Type II Diabetic, 
Insulin Only 
0.67 1.96 (0.58, 6.59) 0.28 
Type II Diabetic, 
Oral Pills and 
Insulin 
-0.26 0.77 (0.17, 3.55) 0.74 
Unknown Diabetic -0.14 0.87 (0.18, 4.10) 0.86 
Non-Diabetic Ref -- -- -- 
Age, 1-year -0.02 0.98 (0.97, 0.99) 0.03 
BMI Category     
Underweight 0.16 1.17 (0.59, 2.33) 0.65 
Normal Weight Ref -- -- -- 
Overweight -0.14 0.87 (0.70, 1.07) 0.18 
Insurance     
Medicare/Medicaid 0.05 1.05 (0.62, 1.76) 0.86 
VA/Tricare 0.50 1.65 (0.85, 3.17) 0.14 
Private Insurance Ref -- -- -- 
Uninsured 0.25 1.28 (0.95, 1.72) 0.10 
Unknown 0.002 1.00 (0.38, 2.63) 1.00 
Education Level     
High school 
diploma or less 
0.02 1.02 (0.63, 1.65) 0.93 
GED 0.02 1.02 (0.48, 2.20) 0.95 
Vocational or 
training certificate 
0.15 1.16 (0.71, 1.88) 0.56 
Some college or 
associate’s degree 
0.24 1.27 (1.03, 1.56) 0.03 
Bachelor’s degree 
or higher 
Ref -- -- -- 
Other 0.07 1.07 (0.61, 1.87) 0.82 
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Table 9. Continued. 
Level of Activity     
Sedentary 0.03 1.04 (0.76, 1.41) 0.82 
Moderately Active -0.03 0.97 (0.75, 1.25) 0.82 
Very Active Ref -- -- -- 
General Health 
Condition 
    
Excellent Ref -- -- -- 
Very Good 0.02 1.02 (0.76, 1.35) 0.91 
Good 0.20 1.22 (0.89, 1.68) 0.21 
Fair 0.35 1.42 (0.95, 2.13) 0.09 
Poor 0.46 1.59 (0.73, 3.45) 0.24 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate 0.12 1.13 (0.84, 1.52) 0.43 
Large 0.27 1.30 (0.95, 1.79) 0.10 
Overwhelming 0.27 1.54 (1.03, 2.28) 0.03 
Problems 
Controlling Worry 
    
Yes, in the past 12 
months 
-0.12 0.88 (0.67, 1.17) 0.38 
Yes, in my lifetime -0.13 0.88 (0.69, 1.12) 0.31 
No Ref -- -- -- 
Excessive Anxiety 
or Worry 
    
Yes, in the past 12 
months 
-0.16 0.85 (0.36, 2.02) 0.72 
Yes, in my lifetime -0.20 0.82 (0.35, 1.93) 0.65 
No Ref -- -- -- 
Trying to Lose 
Weight 
0.11 1.12 (0.91, 1.37) 0.28 
Frequent Yeast 
Infections 
-0.04 0.96 (0.71, 1.29) 0.78 
General Pelvic 
Pain 
0.22 1.24 (0.94, 1.64) 0.12 
Infertility 0.61 1.85 (1.30, 2.64) 0.0007 
Painful or 
Prolonged 
Menstrual Cycles 
0.27 1.31 (1.08, 1.60) 0.006 
PMS/PMDD 0.05 1.05 (0.81, 1.36) 0.74 
Polycystic Ovarian 
Syndrome 
0.53 1.70 (1.21, 2.39) 0.002 
Prolonged/Heavy 
Menses 
0.36 1.44 (1.17, 1.76) 0.0006 
Severe Hot Flashes 0.57 1.77 (1.27, 2.46) 0.0007 
Vaginal Dryness 0.26 1.30 (1.04, 1.62) 0.02 
Vulvar Pain 0.31 1.36 (0.96, 1.95) 0.09 
Other 
Gynecological 
Conditions 
0.33 1.39 (0.83, 2.34) 0.21 
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Table 9. Continued. 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.06 0.94 (0.76, 1.15) 0.54 
Likely to eliminate 
menstruation 
0.74 2.10 (1.58, 2.80) <.0001 
Not likely to impact 
menstruation 
-0.11 0.90 (0.59, 1.36) 0.61 
In this fully-adjusted logistic regression analysis using the expanded diabetes variable, age, infertility, prolonged or 
painful menstrual cycles, PCOS, prolonged or heavy menses, severe hot flashes, and vaginal dryness managed to 
achieve statistical significance. In the expanded diabetes variable, only type II diabetics controlled by diet alone 
managed to achieve significance.. 
 
 Given the number of independent variables analyzed, these models could suffer from 
over-adjustment. Table 10 presents a reduced model utilizing key potential confounders (based 
on the literature) in the analysis, which include age, BMI, level of activity, current stress level, 
PCOS, and birth control level. Age has a significant effect on the prevalence of type II diabetes, 
which composes a majority of diabetes cases.40-42 Age is also known to have a regulatory impact 
on menstrual cycles. BMI is well known to be associated with diabetes41,43, and BMI was also 
been shown to be associated with irregular menstruation in adolescent girls in a 2014 Pakistani 
study.44 Increased physical activity has been shown to have some connection to menstrual cycle 
regulation and frequency, though the physiological function creating such a phenomenon is not 
well understood.45 Physical activity has also been shown to be highly associated with 
diabetes.41,43 The influence of mental stress on menstruation is well-known, often leading to 
missed cycles. In diabetes, a 2017 study showed that mental stress is highly associated with 
unhealthy eating patterns in young adults, which, in turn, influence the prevalence of diabetes.46 
The relationship between diabetes and PCOS, as well as between menstrual cycle irregularities 
and PCOS, was discussed in the literature review. Birth control, in all its various forms, is 
pharmacological agent utilized not only to regulate conception, but also to control, provoke, or 
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eliminate menstrual cycles. Birth control is also known to fluctuate blood glucose levels and 
“exacerbate DM.”47 
 The dichotomous diabetes variable was utilized over the expanded diabetes variable 
because of low numbers of observations in cell counts in the expanded diabetes variable. In this 
model, almost all included variables had at least one stratum gain statistical significance. Of 
primary interest, the dichotomous diabetes variable was significant, indicating diabetic woman 
had 1.53 times the odds of self-reporting menstrual cycle irregularities versus non-diabetic 
women. Being sedentary was statistically significant, and increased odds of self-reporting 
menstrual cycle regularities compared to very active women, seemingly contradicting the lack of 
statistical significance for overweight women. This could suggest multicollinearity between the 
variables. 
Table 10. Reduced logistic regression analysis, utilizing the dichotomous diabetes variable and 
key confounders. 
Variable Beta Estimate Odds Ratio 95% CI Pr > ChiSq 
Diabetes Status 0.42 1.53 (1.12, 2.07) 0.006 
Age -0.02 0.98 (0.97, 0.99) 0.003 
BMI Category     
Underweight 0.31 1.37 (0.81, 2.31) 0.24 
Normal Weight Ref -- -- -- 
Overweight 0.04 1.04 (0.89, 1.21) 0.65 
Level of Activity     
Sedentary 0.27 1.31 (1.02, 1.67) 0.03 
Moderately Active 0.11 1.11 (0.90, 1.37) 0.32 
Very Active Ref -- -- -- 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate 0.21 1.24 (1.00, 1.54) 0.05 
Large 0.51 1.66 (1.32, 2.11) <.0001 
Overwhelming 0.74 2.10 (1.54, 2.88) <.0001 
Polycystic Ovarian 
Syndrome 
0.77 2.16 (1.65, 2.83) <.0001 
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Table 10. Continued. 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.22 0.80 (0.70, 0.95) 0.01 
Likely to eliminate 
menstruation 
0.64 1.89 (1.50, 2.38) <.0001 
Not likely to impact 
menstruation 
-0.07 0.93 (0.64, 1.35) 0.71 
In this reduced-adjusted logistic regression analysis, diabetes, age, stress level, PCOS, and birth control level were 
shown to be statistically significant.. 
 
Sensitivity Analyses 
 PCOS was shown to be very strongly significant in each of the logistic regression 
models. PCOS was not considered as an effect modifier within the context of this analysis due to 
unresolved questions regarding the direction of flow of the causal pathway between menstrual 
cycle regularities and the disease, as well as diabetes and the disease. The strength of the 
association, however, could indicate some influence in the causal pathway between diabetes and 
menstrual cycle irregularities. A reduced logistic regression analysis stratified by PCOS status 
can be found in the Appendix in Table 11 and Table 12. There is no literature to defend such a 
stratification, but the strength of the association from Table 8, Table 9, and Table 10, along with 
the physiology and hallmarks of the disease, created an interesting question that could contribute 
to discussions surrounding PCOS. 
 Table 11 presents the reduced adjusted logistic regression analysis for women reporting 
no PCOS diagnosis (n = 3,941). In this model, diabetes remained significant, decreasing slightly 
compared to the result from Table 10 to an odds ratio of 1.49 (compared to Table 10’s 1.53). 
Stress is highly significant in the model, within even a slight increase in stress to moderate 
increasing the odds of a woman self-reporting menstrual cycle irregularities by 31% when 
compared to a woman with a small level of stress. 
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 The reduced adjusted logistic regression analysis for women reporting a PCOS diagnosis 
(n=304) can be found in Table 12. In this model, all variables in the reduced analysis lose 
statistical significance, with the exception of age. Odds of self-reporting menstrual cycle 
irregularities among diabetic women increase to 1.76 times that of non-diabetic women, 
compared to the 1.49 odds found in Table 11 in the same comparison group. The effect of age on 
self-reporting menstrual cycle irregularities is slightly more protective than in Table 12. 
Curiously, stress, which was highly significant in the population reporting no menstrual cycle 
irregularities, is highly insignificant in this population, with overwhelming stress showing a 
protective effect. This could primarily be due to a small number of observations in this particular 
cell (n = 35, composing 11.51% of the population of women reporting a PCOS diagnosis). Also 
of interest is that birth control, regardless of categorization, is shown to be protective across all 
strata.  
 The results of this analysis indicate a fascinating relationship between the variables and 
PCOS status, indicating an interesting direction for future research. Adding the gynecological 
conditions found in the fully adjusted models in Table 8 and Table 9 could yield a significantly 
different result. It is also important to consider that many of the results in Table 12 could be due 
to small numbers in cell counts in the data, especially when considering that the sample 
population measured for this analysis consisted of only 304 subjects. 
  
DISCUSSION 
 Overall, the results of this analysis yielded conflicting and inconclusive results in this 
evaluation of the relationship between diabetes and menstrual cycle regularity status. The logistic 
regression analyses in Table 8 and Table 9, accounting for all identified potential confounders, 
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did not show a significant association between diabetes and menstrual dysregulation.  Many of 
the gynecological conditions are highly correlated, and reporting one condition could lead to 
reporting others; for instance, a woman reporting general pelvic pain could also be reporting 
other gynecological conditions, which could result in biased estimates from the model. The 
reduced logistic regression analysis in Table 10, however, showed diabetes being statistically 
significant. The bivariate odds ratios in Table 1 and Table 5 also showed a strong relationship 
between diabetic status and menstrual cycle irregularities. The findings in Table 1, Table 5, and 
Table 10 are all consistent with findings in the 1992 Danish study15, a 2003 study17, and a 2010 
Greek study.18  
 The expanded diabetes variable in the fully-adjusted logistic regression analysis in Table 
9, however, showed one subtype of diabetes (Type II diabetes controlled through diet only) as 
significantly associated with menstrual dysregulation. This result is possibly consistent with the 
findings from the 1995 Yeshaya and colleagues study16 and a 2010 Chilean study20 that found 
that menstrual disturbances were found only among women with poorly controlled diabetes. 
These women are only treating their diabetes through lifestyle choices, which may suggest 
poorer control of the disease in these women than among women who do utilize pharmacological 
treatment. On the other hand, it may indicate less severe diabetes. However, it is important to 
remember that there are a very small number of observations analyzed in this particular cell; the 
statistical power may not be adequate to make such a determination. 
 Age was found to be protective against irregular menstrual cycles in Table 8, Table 9, 
and Table 10, which is consistent with common knowledge regarding the regulatory impact of 
age on menstrual cycles. Birth control likely to eliminate menstrual cycles was also significant in 
all three models, with an odds ratio of 2.10 in Table 8 and Table 9 for a woman taking a birth 
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control method likely to eliminate menstrual cycles compared to a woman not taking birth 
control. In Table 10, these odds decreased to 89% greater among women taking a birth control 
method likely to eliminate menstrual cycle compared to women not taking birth control. Table 
10 also indicated a significant decrease in odds of self-reporting irregular menstrual cycles 
among women taking a birth control method likely to provoke menstrual cycles compared to 
women taking no birth control. 
 Being overweight was shown to be protective in all three models, though failed to 
achieve statistical significance in any of the models. There are many possible explanations for 
this particular result. It is important to remember that, inherently, BMI does not account for 
muscle mass, and so women with a high volume of muscle mass could be incorrectly 
categorized. Birth control could also be another explanation. A chi-square analysis of the 
categorical BMI variable and the birth control level variable showed high correlation (p-value 
<.0001). 55.72% of overweight women reported using no birth control, compared to 49.72% of 
women with a normal BMI and 54.41% of women categorized as underweight. A larger 
percentage of overweight women were utilizing a birth control method not likely to impact 
menstruation than normal weight or underweight women (5.30% for overweight women, 
compared to 2.33% for normal weight women and 1.47% for underweight women). Overweight 
women were also more likely to use a method of birth control likely to eliminate menstrual 
cycles than underweight or normal weight women (prevalence ratios of 1.42 and 1.12, 
respectively). Another explanation could be strong associations with comorbid gynecological 
conditions of BMI. For example, 12.59% of overweight women also reported a PMS or PMDD 
diagnosis compared to 8.33% of underweight women and 7.57% of normal weight women (p-
value <.0001). Similarly, 10.40% of overweight women also reported a PCOS diagnosis while 
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3.08% of normal weight women and 2.78% of underweight women reported the condition (p-
value <.0001). 
 Finally, the significance of variables such as age, severe hot flashes, and vaginal dryness 
in the fully-adjusted models in Table 8 and Table 9 could indicate poor control for menopause in 
the models. The average age for perimenopause (45)29 was utilized as the control for menopause 
after indication that menopause outcomes in the dataset were rather unstable. Though the control 
for menopause may have been appropriate, these symptoms may indicate that the method for 
control was not adequate. A different control methodology for menopause could yield 
significantly different results. A fully-adjusted logistic regression analysis with women reporting 
severe hot flashes, most commonly associated with menopause, eliminated from the sample 
population can be found in the Appendix in Table 13. There are other conditions that can cause 
severe hot flashes, such as thyroid disorders, but this provided another proxy for control of 
menopause in the sample. 
 After further restricting the population to eliminate women reporting severe hot flashes as 
another proxy for menopause status, the sample contained 4,002 observations. Within this 
population, 1,060 women reported menstrual cycle irregularities (p-value <.0001) and 220 
women reported diabetes (p-value <.0001). The average age of this sample, overall, was 33.50 
(SD 6.71) and the average BMI was 27.81 (SD 7.56). Curiously, the population in this analysis is 
even more well-educated than the study population, as designed in the methods, with the largest 
percentage of women in this population reporting post-graduate training (36.43%), and the 
second largest percentage indicating possession of a bachelor’s degree (29.47%).  
 In this model, the removal of women indicating severe hot flashes created a rather 
dramatic alteration in the odds found in Table 8 and Table 9, with the odds a diabetic woman in 
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this study population having 1.51 times the odds of self-reporting menstrual cycle irregularities 
compared to a non-diabetic woman. This analysis, when compared to the results of Table 8 and 
Table 9, indicates that control for menopause in the study population may not have been 
adequate to account for the population of pre-menopausal or menopausal women in this 
population. Further analysis and examination is needed to control and modify such a population. 
 The primary strength of this analysis were the unique variables within the dataset. A 
variable categorizing diabetic status into many levels provided unique insight into diabetes 
within this analysis. The variable allowed examination of several different types and treatments 
of diabetes, though low cell counts in many of the strata limited analyses. This variable created a 
unique opportunity to evaluate a population beyond dichotomous variables and gain insight into 
associations and possible mechanistic relationships. The population studied in this analysis was 
also large, providing increased statistical power to these analyses and providing insight into an 
understudied population regarding this question. This study also included an in-depth 
characterization of women’s health issues among this population of women. A careful analysis of 
potential confounders for this question within this population also provided more strength to this 
population. 
 The dataset does suffer from a significant amount of selection bias based on the 
population chosen for analysis from KWHR and selection bias. Furthermore, the population 
within this analysis is more white and more educated than the general population, and, thus, is 
not generalizable to a more general population. Limited information on variables and 
observations could be leading to misinterpretation of results and observations. Irregular 
menstruation, for instance, is defined by several different dysfunctions in menstrual cycles.4 The 
codebook does not define how such a variable was defined to the survey takers, or if the survey 
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takers assigned their own definition to the variable when self-reporting such status. The length of 
cycle variable also presents an interesting conundrum when considering menstrual cycle 
regularity status, as the lowest grouping of time for the variable is 2 months or less, which could 
result in women with irregular menstrual cycles being categorized in the referent group. The 
observations and classification was also dependent upon accurate self-reporting. Women who are 
not aware they possess certain conditions may be causing unknown misclassification bias in this 
population. Other measures, such as BMI, rely entirely on self-reported data, and so the data may 
not reflect the reality for many women in this population. Furthermore, cross-sectional studies 
cannot determine causation, and thus can only speak of associations rather than provide insight 
into mechanistic relationships regarding menstrual cycle status and diabetes. 
 
CONCLUSION 
 A strong association was consistently shown between diabetes and menstrual cycle 
irregularities in all the analyses, despite several analyses lacking statistical significance. 
Identifying multicollinearity, adjusting the model, and better identifying and analyzing potential 
indicators of menopause status could yield significantly different results in the analysis. In the 
expanded diabetes variable, type II diabetics controlling through diet alone were shown to be 
significant, even in the fully-adjusted model, indicating an interesting relationship that could be 
explored in further study. Small numbers within this category, however, could have a significant 
effect on the strength, requiring this result to considered with caution.  
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APPENDIX 
 
Logistic Regression Analyses Stratified by PCOS Status 
 
Table 11. Reduced adjusted logistic regression analysis and adjusted odds ratios, utilizing the 
dichotomous diabetes variable and stratified for women reporting no PCOS diagnosis. 
Variable Beta Estimate Odds Ratio 95% CI Pr > ChiSq 
Diabetes Status 0.40 1.49 (1.04, 2.14) 0.03 
Age -0.01 0.99 (0.97, 1.00) 0.01 
BMI Category     
Underweight 0.41 1.51 (0.89, 2.56) 0.13 
Normal Weight Ref -- -- -- 
Overweight 0.04 1.04 (0.88, 1.22) 0.65 
Level of Activity     
Sedentary 0.28 1.32 (1.02, 1.70) 0.04 
Moderately Active 0.10 1.11 (0.89, 1.37) 0.35 
Very Active Ref -- -- -- 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate 0.27 1.31 (1.04, 1.65) 0.02 
Large 0.55 1.73 (1.35, 2.21) <.0001 
Overwhelming 0.86 2.36 (1.70, 3.29) <.0001 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.22 0.80 (0.67, 0.96) 0.02 
Likely to eliminate 
menstruation 
0.70 2.02 (1.59, 2.56) <.0001 
Not likely to impact 
menstruation 
0.07 1.07 (0.73, 1.57) 0.73 
In this reduced logistic regression analysis stratified by no PCOS status, diabetes, age, activity level, stress level, 
and birth control level were all shown to be statistically significant. 
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Table 12. Reduced adjusted logistic regression analysis and adjusted odds ratios, utilizing the 
dichotomous diabetes variable and stratified for women reporting a PCOS diagnosis. 
Variable Beta Estimate Odds Ratio Chi-Square Pr > ChiSq 
Diabetes Status 0.57 1.76 (0.97, 3.18) 0.06 
Age -0.05 0.95 (0.91, 1.00) 0.03 
BMI Category     
Underweight -14.13 <.001 (<.001, >999.999) 0.99 
Normal Weight Ref -- -- -- 
Overweight -0.21 0.81 (0.42, 1.58) 0.54 
Level of Activity     
Sedentary 0.39 1.48 (0.56, 3.88) 0.43 
Moderately Active 0.31 1.36 (0.56, 3.28) 0.50 
Very Active Ref -- -- -- 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate -0.28 0.76 (0.34, 1.68) 0.50 
Large 0.23 1.25 (0.54, 2.91) 0.60 
Overwhelming -0.07 0.93 (0.32, 2.77) 0.90 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.16 0.85 (0.48, 1.52) 0.59 
Likely to eliminate 
menstruation 
-0.29 0.75 (0.29, 1.95) 0.55 
Not likely to impact 
menstruation 
-1.24 0.29 (0.07, 1.14) 0.08 
In this analysis, age was the only variable that managed to achieve statistical significance. The association with 
diabetes in this analysis was larger than the association in Table 11. 
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Logistic Regression Analysis Eliminating Severe Hot Flashes 
 
Table 13. Reduced-adjusted logistic regression analysis for sample population excluding women 
reporting severe hot flashes, utilizing the dichotomous diabetes variable. 
Variable Beta Estimate Odds Ratio 95% CI Pr > ChiSq 
Diabetes Status 0.41 1.51 (1.09, 2.08) 0.01 
Age -0.02 0.98 (0.97, 0.99) 0.002 
BMI Category     
Underweight 0.27 1.31 (0.76, 2.26) 0.33 
Normal Weight Ref -- -- -- 
Overweight 0.05 1.05 (0.89, 1.24) 0.54 
Level of Activity     
Sedentary 0.26 1.30 (1.00, 1.68) 0.05 
Moderately Active 0.13 1.14 (0.92, 1.42) 0.23 
Very Active Ref -- -- -- 
Current Stress 
Level 
    
Small Ref -- -- -- 
Moderate 0.22 1.24 (0.99, 1.56) 0.06 
Large 0.47 1.60 (1.25, 2.04) 0.0002 
Overwhelming 0.69 2.00 (1.43, 2.78) <.0001 
Polycystic Ovarian 
Syndrome 
0.78 2.19 (1.66, 2.89) <.0001 
Birth Control 
Level 
    
No birth control Ref -- -- -- 
Likely to provoke 
menstruation 
-0.22 0.80 (0.67, 0.95) 0.01 
Likely to eliminate 
menstruation 
0.67 1.95 (1.54, 2.47) <.0001 
Not likely to impact 
menstruation 
-0.15 0.86 (0.57, 1.29) 0.46 
In this analysis, diabetes, age, stress level, PCOS, and birth control level were shown to be significant. Diabetes 
showed a strong association with menstrual cycle regularities in this adjusted analysis. 
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